Quantitative assessment of tumor angiogenesis using real-time motion-compensated contrast-enhanced ultrasound imaging

Angiogenesis

Volumn 15, Issue 3, 2012, Pages 433-442

  Pysz, Marybeth A ^a   Guracar, Ismayil ^b   Foygel, Kira ^a   Tian, Lu ^c   Willmann, Jürgen K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Siemens Healthcare   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Cancer; Maximum intensity persistence; Microbubbles; MIP; Ultrasound; Vascular disrupting agent; VDA

Indexed keywords

ECHO CONTRAST MEDIUM; MICROMARKERS; PERFLUBUTANE CONTAINING CONTRAST MICROBUBBLE; UNCLASSIFIED DRUG; VADIMEZAN;

ACCURACY; ALGORITHM; ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFACT REDUCTION; BLOOD VESSEL PARAMETERS; CANCER CELL CULTURE; CANCER SIZE; COLON ADENOCARCINOMA; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOGRAPHY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IMAGE QUALITY; IMAGING AND DISPLAY; IN VIVO STUDY; MAXIMUM INTENSITY PERSISTENCE; MICROVESSEL DENSITY; MONITORING; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME MOTION COMPENSATION ALGORITHM; RELIABILITY; REPRODUCIBILITY; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; ULTRASOUND SCANNER; ULTRASOUND TRANSDUCER;

ALGORITHMS; ANIMALS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICE; MICE, NUDE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TRANSPLANTATION, HETEROLOGOUS; ULTRASONICS;

ANIMALIA; MUS;

EID: 84865137691     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-012-9271-3     Document Type: Article

References (58)

1. Wilson SR, Burns PN (2010) Microbubble-enhanced US in body imaging: what role? Radiology 257:24-39
2. Lassau N, Chami L, Chebil M, Benatsou B, Bidault S, Girard E, Abboud G, Roche A (2011) Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments. Discov Med 11:18-24
3. Wilson SR, Jang HJ, Kim TK, Iijima H, Kamiyama N, Burns PN (2008) Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography. AJR Am J Roentgenol 190:691-695 (Pubitemid 351304513)
4. Aigner F, Mitterberger M, Rehder P, Pallwein L, Junker D, Horninger W, Frauscher F (2010) Status of transrectal ultrasound imaging of the prostate. J Endourol 24:685-691
5. Aigner F, Pallwein L, Mitterberger M, Pinggera GM, Mikuz G, Horninger W, Frauscher F (2009) Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate. BJU Int 103:458-463
6. DePriest PD, DeSimone CP (2003) Ultrasound screening for the early detection of ovarian cancer. J Clin Oncol 21:194s-199s
7. Fleischer AC, Lyshchik A, Andreotti RF, Hwang M, Jones HW III, Fishman DA (2010) Advances in sonographic detection of ovarian cancer: depiction of tumor neovascularity with microbubbles. AJR Am J Roentgenol 194:343-348
8. Fleischer AC, Lyshchik A, Jones HW III, Crispens MA, Andreotti RF, Williams PK, Fishman DA (2009) Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonography. J Ultrasound Med 28:1273-1280
9. Gorg C (2007) The forgotten organ: contrast enhanced sonography of the spleen. Eur J Radiol 64:189-201 (Pubitemid 47593064)
10. Fusaroli P, Spada A, Mancino MG, Caletti G (2010) Contrast harmonic echo-endoscopic ultrasound improves accuracy in diagnosis of solid pancreatic masses. Clin Gastroenterol Hepatol 8(629-634):e621-e622
11. Helmstaedter L, Riemann JF (2008) Pancreatic cancer-EUS and early diagnosis. Langenbecks Arch Surg 393:923-927
12. Hohl C, Schmidt T, Honnef D, Gunther RW, Haage P (2007) Ultrasonography of the pancreas. 2. Harmonic imaging. Abdom Imaging 32:150-160 (Pubitemid 46883660)
13. Rickes S, Rauh P, Uhle C, Ensberg D, Monkemuller K, Malfertheiner P (2007) Contrast-enhanced sonography in pancreatic diseases. Eur J Radiol 64:183-188 (Pubitemid 47588754)
14. Correas JM, Claudon M, Tranquart F, Helenon AO (2006) The kidney: imaging with microbubble contrast agents. Ultrasound Q 22:53-66 (Pubitemid 44510228)
15. Xu ZF, Xu HX, Xie XY, Liu GJ, Zheng YL, Lu MD (2010) Renal cell carcinoma and renal angiomyolipoma: differential diagnosis with real-time contrast-enhanced ultrasonography. J Ultrasound Med 29:709-717
16. Doust BD (1976) The use of ultrasound in the diagnosis of gastroenterological disease. Gastroenterology 70:602-610
17. Nylund K, Hausken T, Gilja OH (2010) Ultrasound and inflammatory bowel disease. Ultrasound Q 26:3-15
18. Nylund K, Odegaard S, Hausken T, Folvik G, Lied GA, Viola I, Hauser H, Gilja OH (2009) Sonography of the small intestine. World J Gastroenterol 15:1319-1330
19. Contamin H, Rioufol G, Bettinger T, Helbert A, Portier KG, Lepage OM, Thomas R, Broillet A, Tranquart F, Schneider M (2012) A minimally-invasive closed chest myocardial occlusion-reperfusion model in rhesus monkeys (Macaca mulatta): monitoring by contrast-enhanced ultrasound imaging. Int J Cardiovasc Imaging 28:531-542
20. Staub D, Partovi S, Schinkel AF, Coll B, Uthoff H, Aschwanden M, Jaeger KA, Feinstein SB (2011) Correlation of carotid artery atherosclerotic lesion echogenicity and severity at standard US with intraplaque neovascularization detected at contrast-enhanced US. Radiology 258:618-626
21. Staub D, Schinkel AF, Coll B, Coli S, van der Steen AF, Reed JD, Krueger C, Thomenius KE, Adam D, Sijbrands EJ, ten Cate FJ, Feinstein SB (2010) Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques. JACC Cardiovasc Imaging 3:761-771
22. Balleyguier C, Opolon P, Mathieu MC, Athanasiou A, Garbay JR, Delaloge S, Dromain C (2009) New potential and applications of contrast-enhanced ultrasound of the breast: Own investigations and review of the literature. Eur J Radiol 69:14-23
23. Caproni N, Marchisio F, Pecchi A, Canossi B, Battista R, D'Alimonte P, Torricelli P (2010) Contrast-enhanced ultrasound in the characterisation of breast masses: utility of quantitative analysis in comparison with MRI. Eur Radiol 20:1384-1395
24. Hooley RJ, Andrejeva L, Scoutt LM (2011) Breast cancer screening and problem solving using mammography, ultrasound, and magnetic resonance imaging. Ultrasound Q 27:23-47
25. Molinari F, Mantovani A, Deandrea M, Limone P, Garberoglio R, Suri JS (2010) Characterization of single thyroid nodules by contrast-enhanced 3-D ultrasound. Ultrasound Med Biol 36:1616-1625
26. Zengel P, Siedek V, Berghaus A, Clevert DA (2010) Intraductally applied contrast-enhanced ultrasound (IA-CEUS) for improved visualization of obstructive diseases of the salivary glands, primary results. Clin Hemorheol Microcirc 45:193-205
27. de Lange C, Brabrand K, Emblem KE, Bjornerud A, Loberg EM, Saugstad OD, Munkeby BH (2011) Cerebral perfusion in perinatal hypoxia and resuscitation assessed by transcranial contrast-enhanced ultrasound and 3 T MRI in newborn pigs. Invest Radiol 46:686-696
28. Lamuraglia M, Bridal SL, Santin M, Izzi G, Rixe O, Paradiso A, Lucidarme O (2010) Clinical relevance of contrast-enhanced ultrasound in monitoring anti-angiogenic therapy of cancer: current status and perspectives. Crit Rev Oncol Hematol 73:202-212
29. Yoshida K, Hirokawa T, Moriyasu F, Liu L, Liu GJ, Yamada M, Imai Y (2010) Arterial-phase contrast-enhanced ultrasonography for evaluating anti-angiogenesis treatment: a pilot study. World J Gastroenterol 17:1045-1050
30. Palmowski M, Lederle W, Gaetjens J, Socher M, Hauff P, Bzyl J, Semmler W, Gunther RW, Kiessling F (2010) Comparison of conventional time-intensity curves vs. maximum intensity over time for post-processing of dynamic contrast-enhanced ultrasound. Eur J Radiol 75:e149-e153
31. Hoyt K, Warram JM, Umphrey H, Belt L, Lockhart ME, Robbin ML, Zinn KR (2010) Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networks. J Ultrasound Med 29:577-585
32. Pollard RE, Sadlowski AR, Bloch SH, Murray L, Wisner ER, Griffey S, Ferrara KW (2002) Contrast-assisted destruction-replenishment ultrasound for the assessment of tumor microvasculature in a rat model. Technol Cancer Res Treat 1:459-470 (Pubitemid 36548522)
33. Watson KD, Hu X, Lai CY, Lindfors HA, Hu-Lowe DD, Tuthill TA, Shalinsky DR, Ferrara KW (2011) Novel ultrasound and DCE-MRI analyses after antiangiogenic treatment with a selective VEGF receptor inhibitor. Ultrasound Med Biol 37:909-921
34. Zhou JH, Cao LH, Liu JB, Zheng W, Liu M, Luo RZ, Han F, Li AH (2011) Quantitative assessment of tumor blood flow in mice after treatment with different doses of an antiangiogenic agent with contrast-enhanced destruction-replenishment US. Radiology 259:406-413
35. Arditi M, Frinking PJ, Zhou X, Rognin NG (2006) A new formalism for the quantification of tissue perfusion by the destruction-replenishment method in contrast ultrasound imaging. IEEE Trans Ultrason Ferroelectr Freq Control 53:1118-1129 (Pubitemid 46405092)
36. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S (1998) Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 97:473-483 (Pubitemid 28090220)
37. Pysz MA, Foygel K, Panje CM, Needles A, Tian L, Willmann JK (2011) Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging. Invest Radiol 46:187-195
38. Zhao H, Xu R, Ouyang Q, Chen L, Dong B, Huihua Y (2010) Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions. Eur J Radiol 73:288-293
39. Dave JK, Forsberg F (2009) Novel automated motion compensation technique for producing cumulative maximum intensity subharmonic images. Ultrasound Med Biol 35:1555-1563
40. Bohs LN, Trahey GE (1991) A novel method for angle independent ultrasonic imaging of blood flow and tissue motion. IEEE Trans Biomed Eng 38:280-286
41. Weidner N (2008) Chapter 14. Measuring intratumoral microvessel density. Methods Enzymol 444:305-323
42. Faria JR, Aarao AR, Jimenez LM, Silva OH, Avelleira JC (2010) Inter-rater concordance study of the PASI (Psoriasis Area and Severity Index). An Bras Dermatol 85:625-629
43. Dindyal S, Kyriakides C (2011) Ultrasound microbubble contrast and current clinical applications. Recent Pat Cardiovasc Drug Discov 6:27-41
44. McCarville MB (2011) Contrast-enhanced sonography in pediatrics. Pediatr Radiol 41(Suppl 1):S238-S242
45. Xu HX (2009) Contrast-enhanced ultrasound: the evolving applications. World J Radiol 1:15-24
46. Pochon S, Tardy I, Bussat P, Bettinger T, Brochot J, von Wronski M, Passantino L, Schneider M (2010) BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol 45:89-95
47. Pysz MA, Foygel K, Rosenberg J, Gambhir SS, Schneider M, Willmann JK (2010) Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology 256:519-527
48. Palmowski M, Huppert J, Ladewig G, Hauff P, Reinhardt M, Mueller MM, Woenne EC, Jenne JW, Maurer M, Kauffmann GW, Semmler W, Kiessling F (2008) Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects. Mol Cancer Ther 7:101-109
49. Deshpande N, Ren Y, Foygel K, Rosenberg J, Willmann JK (2011) Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging. Radiology 258:804-811
50. Lassau N, Koscielny S, Chami L, Chebil M, Benatsou B, Roche A, Ducreux M, Malka D, Boige V (2011) Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification-preliminary results. Radiology 258:291-300
51. Lavisse S, Lejeune P, Rouffiac V, Elie N, Bribes E, Demers B, Vrignaud P, Bissery MC, Brule A, Koscielny S, Peronneau P, Lassau N (2008) Early quantitative evaluation of a tumor vasculature disruptive agent AVE8062 using dynamic contrast-enhanced ultrasonography. Invest Radiol 43:100-111
52. Williams R, Hudson JM, Lloyd BA, Sureshkumar AR, Lueck G, Milot L, Atri M, Bjarnason GA, Burns PN (2011) Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy. Radiology 260:581-590
53. Averkiou M, Lampaskis M, Kyriakopoulou K, Skarlos D, Klouvas G, Strouthos C, Leen E (2010) Quantification of tumor microvascularity with respiratory gated contrast enhanced ultrasound for monitoring therapy. Ultrasound Med Biol 36:68-77
54. Mule S, De Cesare A, Frouin F, Lucidarme O, Herment A (2007) An original methodology for quantitative assessment of perfusion in small animal studies using contrast-enhanced ultrasound. Conf Proc IEEE Eng Med Biol Soc 2007:347-350
55. Frangi AF, Laclaustra M, Lamata P (2003) A registration-based approach to quantify flow-mediated dilation (FMD) of the brachial artery in ultrasound image sequences. IEEE Trans Med Imaging 22:1458-1469
56. de Oliveira PL, de Senneville BD, Dragonu I, Moonen CT (2010) Rapid motion correction in MR-guided high-intensity focused ultrasound heating using real-time ultrasound echo information. NMR Biomed 23:1103-1108
57. Mule S, Kachenoura N, Lucidarme O, De Oliveira A, Pellot-Barakat C, Herment A, Frouin F (2011) An automatic respiratory gating method for the improvement of microcirculation evaluation: application to contrast-enhanced ultrasound studies of focal liver lesions. Phys Med Biol 56:5153-5165
58. Pollard RE, Dayton PA, Watson KD, Hu X, Guracar IM, Ferrara KW (2009) Motion corrected cadence CPS ultrasound for quantifying response to vasoactive drugs in a rat kidney model. Urology 74:675-681